205 related articles for article (PubMed ID: 11420044)
1. MHC class II expression is regulated in dendritic cells independently of invariant chain degradation.
Villadangos JA; Cardoso M; Steptoe RJ; van Berkel D; Pooley J; Carbone FR; Shortman K
Immunity; 2001 Jun; 14(6):739-49. PubMed ID: 11420044
[TBL] [Abstract][Full Text] [Related]
2. The protease inhibitor cystatin C is differentially expressed among dendritic cell populations, but does not control antigen presentation.
El-Sukkari D; Wilson NS; Hakansson K; Steptoe RJ; Grubb A; Shortman K; Villadangos JA
J Immunol; 2003 Nov; 171(10):5003-11. PubMed ID: 14607896
[TBL] [Abstract][Full Text] [Related]
3. Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages.
Shi GP; Bryant RA; Riese R; Verhelst S; Driessen C; Li Z; Bromme D; Ploegh HL; Chapman HA
J Exp Med; 2000 Apr; 191(7):1177-86. PubMed ID: 10748235
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells regulate exposure of MHC class II at their plasma membrane by oligoubiquitination.
van Niel G; Wubbolts R; Ten Broeke T; Buschow SI; Ossendorp FA; Melief CJ; Raposo G; van Balkom BW; Stoorvogel W
Immunity; 2006 Dec; 25(6):885-94. PubMed ID: 17174123
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cells constitutively present self antigens in their immature state in vivo and regulate antigen presentation by controlling the rates of MHC class II synthesis and endocytosis.
Wilson NS; El-Sukkari D; Villadangos JA
Blood; 2004 Mar; 103(6):2187-95. PubMed ID: 14604956
[TBL] [Abstract][Full Text] [Related]
6. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli.
Inaba K; Turley S; Iyoda T; Yamaide F; Shimoyama S; Reis e Sousa C; Germain RN; Mellman I; Steinman RM
J Exp Med; 2000 Mar; 191(6):927-36. PubMed ID: 10727455
[TBL] [Abstract][Full Text] [Related]
7. MHC class II and invariant chain biosynthesis and transport during maturation of human precursor dendritic cells.
Engering AJ; Richters CD; Fluitsma DM; van Pelt AM; Kamperdijk EW; Hoefsmit EC; Pieters J
Int Immunol; 1998 Nov; 10(11):1713-23. PubMed ID: 9846700
[TBL] [Abstract][Full Text] [Related]
8. Fc epsilon receptor I on dendritic cells delivers IgE-bound multivalent antigens into a cathepsin S-dependent pathway of MHC class II presentation.
Maurer D; Fiebiger E; Reininger B; Ebner C; Petzelbauer P; Shi GP; Chapman HA; Stingl G
J Immunol; 1998 Sep; 161(6):2731-9. PubMed ID: 9743330
[TBL] [Abstract][Full Text] [Related]
9. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains.
Machy P; Serre K; Baillet M; Leserman L
J Immunol; 2002 Feb; 168(3):1172-80. PubMed ID: 11801652
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cells process and present antigens across a range of maturation states.
Veeraswamy RK; Cella M; Colonna M; Unanue ER
J Immunol; 2003 Jun; 170(11):5367-72. PubMed ID: 12759410
[TBL] [Abstract][Full Text] [Related]
11. Endosomal sorting of MHC class II determines antigen presentation by dendritic cells.
van Niel G; Wubbolts R; Stoorvogel W
Curr Opin Cell Biol; 2008 Aug; 20(4):437-44. PubMed ID: 18582577
[TBL] [Abstract][Full Text] [Related]
12. Type I IFN drives a distinctive dendritic cell maturation phenotype that allows continued class II MHC synthesis and antigen processing.
Simmons DP; Wearsch PA; Canaday DH; Meyerson HJ; Liu YC; Wang Y; Boom WH; Harding CV
J Immunol; 2012 Apr; 188(7):3116-26. PubMed ID: 22371391
[TBL] [Abstract][Full Text] [Related]
13. The pathway for MHCII-mediated presentation of endogenous proteins involves peptide transport to the endo-lysosomal compartment.
Dani A; Chaudhry A; Mukherjee P; Rajagopal D; Bhatia S; George A; Bal V; Rath S; Mayor S
J Cell Sci; 2004 Aug; 117(Pt 18):4219-30. PubMed ID: 15316082
[TBL] [Abstract][Full Text] [Related]
14. Control of MHC class II antigen presentation in dendritic cells: a balance between creative and destructive forces.
Villadangos JA; Schnorrer P; Wilson NS
Immunol Rev; 2005 Oct; 207():191-205. PubMed ID: 16181337
[TBL] [Abstract][Full Text] [Related]
15. Maturation of Peyer's patch dendritic cells in vitro upon stimulation via cytokines or CD40 triggering.
Ruedl C; Hubele S
Eur J Immunol; 1997 Jun; 27(6):1325-30. PubMed ID: 9209480
[TBL] [Abstract][Full Text] [Related]
16. MHC class II-restricted antigen processing and presentation.
Pieters J
Adv Immunol; 2000; 75():159-208. PubMed ID: 10879284
[No Abstract] [Full Text] [Related]
17. Dendritic cells from mice lacking the invariant chain express high levels of membrane MHC class II molecules in vivo.
Rovere P; Forquet F; Zimmermann VS; Trucy J; Ricciardi-Castagnoli P; Davoust J
Adv Exp Med Biol; 1997; 417():195-201. PubMed ID: 9286361
[TBL] [Abstract][Full Text] [Related]
18. Endosomally stored MHC class II does not contribute to antigen presentation by dendritic cells at inflammatory conditions.
ten Broeke T; van Niel G; Wauben MH; Wubbolts R; Stoorvogel W
Traffic; 2011 Aug; 12(8):1025-36. PubMed ID: 21518167
[TBL] [Abstract][Full Text] [Related]
19. CpG DNA induces maturation of dendritic cells with distinct effects on nascent and recycling MHC-II antigen-processing mechanisms.
Askew D; Chu RS; Krieg AM; Harding CV
J Immunol; 2000 Dec; 165(12):6889-95. PubMed ID: 11120813
[TBL] [Abstract][Full Text] [Related]
20. Abundant empty class II MHC molecules on the surface of immature dendritic cells.
Santambrogio L; Sato AK; Fischer FR; Dorf ME; Stern LJ
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15050-5. PubMed ID: 10611336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
